Discovering and validating new targets is urgently required to tackle the rise in resistance to antimalarial drugs. Now, inhibition of the enzyme N-myristoyltransferase has been shown to prevent the formation of a critical subcellular organelle in the parasite that causes malaria, leading to death of the parasite.
This is a preview of subscription content, log in via an institution to check access.
References
World Malaria Report 2012 (World Health Organization, 2012).
Guidelines for the Treatment of Malaria 2nd edn, 13–47 (World Health Organization, 2010).
Noedl, H., Se, Z., Schaecher, K., Smith, B. L., Socheat, D. & Fukuda, M. M. N. Engl. J. Med. 359, 2619–2620 (2008).
Dondorp, A. M. et al. Nature Rev. Microbiol. 8, 272–280 (2010).
http://go.nature.com/NuySfh (data accessed 4 December 2013).
Wright, M. H. et al. Nature Chem. 6, 112–121 10.1038/nchem.1830(2014).
Duronio, R. J., Towler, D. A., Heuckeroth, R. O. & Gordon, J. I. Science 243, 796–800 (1989).
Price, H. P. et al. J. Biol. Chem. 278, 7206–7214 (2003).
Pino, P. et al. Cell Host Microbe 12, 824–834 (2012).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Krysiak, J., Sieber, S. Knockout for malaria. Nature Chem 6, 93–94 (2014). https://doi.org/10.1038/nchem.1854
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchem.1854
- Springer Nature Limited